Trial Profile
A Study to Evaluate the Association between Urinary Catecholamines and Lorcaserin Action on Vital Signs in Overweight and Obese Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2016
Price :
$35
*
At a glance
- Drugs Lorcaserin (Primary)
- Indications Obesity
- Focus Biomarker; Pharmacodynamics
- 10 Mar 2016 New trial record